Artificial intelligence is proving to be a game-changer in the early detection of neurodegenerative diseases such as Alzheimer’s and Parkinson’s. AI algorithms can analyze biomarkers, imaging data, and genetic information to identify the earliest signs of these conditions, often before symptoms become clinically apparent. This early detection is crucial for implementing treatments that can slow disease progression and improve the quality of life for patients. By leveraging machine learning and deep learning techniques, AI systems can recognize patterns that are invisible to the human eye, leading to more accurate and timely diagnoses. As research in this area continues to evolve, AI is expected to play an even larger role in the early intervention and management of neurodegenerative diseases, potentially altering the course of these conditions for millions of people worldwide.
Sources : SpringerLink Cureus
